Hedge Fund - Sarissa Capital Management
Biogen Inc. (BIIB)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $166,389,110 | 25.64% | 643,000 | $245.62 |
| 2 | 2023 - Q3 (2023-09-30) | $165,257,430 | 22.26% | 643,000 | $267.47 |
| 3 | 2023 - Q2 (2023-06-30) | $183,158,550 | 18.23% | 643,000 | $297.84 |
| 4 | 2023 - Q1 (2023-03-31) | $178,773,290 | 22.86% | 643,000 | $276.70 |
| 5 | 2022 - Q4 (2022-12-31) | $178,059,560 | 21.19% | 643,000 | $282.44 |
| 6 | 2022 - Q3 (2022-09-30) | $171,681,000 | 19.4% | 643,000 | $212.38 |
| 7 | 2022 - Q2 (2022-06-30) | $131,133,000 | 13.19% | 643,000 | $204.43 |
| 8 | 2022 - Q1 (2022-03-31) | $135,416,000 | 12.79% | 643,000 | $217.46 |
| 9 | 2021 - Q4 (2021-12-31) | $154,269,000 | 13.35% | 643,000 | $257.12 |
| 10 | 2021 - Q3 (2021-09-30) | $181,963,000 | 14.28% | 643,000 | $327.75 |
| 11 | 2021 - Q2 (2021-06-30) | $222,651,000 | 17.7% | 643,000 | $302.94 |
| 12 | 2021 - Q1 (2021-03-31) | $179,879,000 | 17.24% | 643,000 | $269.69 |
| 13 | 2020 - Q4 (2020-12-31) | $157,444,000 | 16.06% | 643,000 | $259.08 |
| 14 | 2020 - Q3 (2020-09-30) | $182,406,000 | 21.47% | 643,000 | $278.91 |
| 15 | 2020 - Q2 (2020-06-30) | $172,034,000 | 19.13% | 643,000 | $300.59 |
| 16 | 2020 - Q1 (2020-03-31) | $203,432,000 | 25.95% | 643,000 | $303.47 |
| 17 | 2019 - Q4 (2019-12-31) | $190,797,000 | 15.83% | 643,000 | $277.46 |
| 18 | 2019 - Q3 (2019-09-30) | $149,703,000 | 18.76% | 643,000 | $232.85 |
| 19 | 2019 - Q2 (2019-06-30) | $150,378,000 | 18.74% | 643,000 | $230.90 |
| 20 | 2019 - Q1 (2019-03-31) | $124,018,000 | 18.67% | 524,658 | $314.89 |
| 21 | 2018 - Q4 (2018-12-31) | $138,982,000 | 30.79% | 461,858 | $319.14 |
| 22 | 2018 - Q3 (2018-09-30) | $163,179,000 | 35.99% | 461,858 | $344.30 |
| 23 | 2018 - Q2 (2018-06-30) | $134,049,000 | 26.87% | 461,858 | $281.15 |
| 24 | 2018 - Q1 (2018-03-31) | $113,322,000 | 26.22% | 413,858 | $310.41 |
| 25 | 2017 - Q4 (2017-12-31) | $131,842,000 | 33.74% | 413,858 | $320.80 |
| 26 | 2017 - Q3 (2017-09-30) | $120,193,000 | 37.09% | 383,858 | $296.11 |
| 27 | 2017 - Q2 (2017-06-30) | $104,163,000 | 34.77% | 383,858 | $264.42 |
| 28 | 2017 - Q1 (2017-03-31) | $84,760,000 | 33.49% | 310,000 | $282.75 |
| 29 | 2016 - Q4 (2016-12-31) | $87,909,000 | 24.21% | 310,000 | $296.43 |
| 30 | 2016 - Q3 (2016-09-30) | $97,039,000 | 22.34% | 310,000 | $296.18 |
| 31 | 2016 - Q2 (2016-06-30) | $74,964,000 | 21.27% | 310,000 | $263.54 |
| 32 | 2016 - Q1 (2016-03-31) | $80,699,000 | 17.78% | 310,000 | $264.15 |
| 33 | 2015 - Q4 (2015-12-31) | $94,969,000 | 18.46% | 310,000 | $287.35 |
The displayed share prices are average quarterly stock market prices.